Blocking rhinoviral adhesion molecule (ICAM-1): potential to prevent COPD exacerbations

• Main Authors: Shukla SD, Hansbro PM, Walters EH
• Format: Article
• Language: English
• Published: Dove Medical Press 2017-05-01
• Series: International Journal of COPD
• Subjects: COPD; Acute exacerbations; ICAM-1; Rhinovirus
• Online Access: https://www.dovepress.com/blocking-rhinoviral-adhesion-molecule-icam-1-potential-to-prevent-copd-peer-reviewed-article-COPD
• ISSN: 1178-2005

Shakti Dhar Shukla,1–3 Philip Michael Hansbro,1–3 Eugene Haydn Walters4 1Priority Research Centre for Healthy Lungs, 2School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, NSW, Australia; 3Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; 4School of Medicine, University of Tasmania, Hobart, TAS, AustraliaAcute exacerbations of COPD (AECOPD) are markers of disease progression and severity, and frequently are used as an outcome variable in interventional studies.1 AECOPD results in increased severity of symptoms and induces disease progression with accelerated decline in lung function and decreased quality of life. The risk of morbidity and mortality is also significantly increased. Most AECOPD (~85%) have an infectious etiology, induced by bacteria and viruses, often rhinovirus (~50%).1View the original paper by Johnston and colleagues.